NCT06611293

Brief Summary

Through the HOPE study, the intention would be to determine whether exhaled breath volatile organic compound (VOC) profiles in Primary care differ from Secondary care. The intention would also be to assess intra-subject variability of participants. This would allow us to determine if the results of breath samples are reproducible regardless of whether they are performed in a Primary or Secondary care environment. This would support the clinical translation of breath research outcomes from studies performed in Secondary care, despite the breath test being intended for use in Primary care. The chief investigator of the HOPE study is Professor George Hanna (Head of Department of Surgery and Cancer, and Professor of Surgical Sciences at Imperial College London).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Feb 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Feb 2025Oct 2026

First Submitted

Initial submission to the registry

September 16, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

September 16, 2024

Last Update Submit

April 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The variation in exhaled breath VOC profile in the participants in Primary versus Secondary Care setting.

    An exploratory analysis will be performed to identify and exclude contaminated samples. Linear mixed models will be fitted for each compound's measurements to estimate components of variation (between individuals, occasions and repeat samples), and confirm that there is no effect of ordering (hospital-GP vs GP-hospital). Repeatability of each day-location combination will be summarised as the intra-class correlation coefficient (ICC) and the coefficient of variation (CV). The observed differences will be compared with the clinically acceptable limits for each VOC to identify the proportion of GP-hospital differences that fall within these limits. For each VOC, the ICC, CV and the limits of agreement with 95% confidence interval will be reported, along with how they compare with the clinically acceptable differences.

    2 years

Secondary Outcomes (1)

  • The intra-subject variability in exhaled breath VOCs when breath is sampled 15 minutes apart on different days.

    2 years

Study Arms (1)

Volunteers taking part in study

Diagnostic Test: Breath test

Interventions

Breath testDIAGNOSTIC_TEST

Participants will perform breath testing in Primary care followed by Secondary care on Day 1. At each location, participants will be asked to perform three breath tests (15 minutes apart). The environmental air will also be sampled. This entire process will be repeated in the reverse order (i.e. breath testing in Secondary care followed by Primary care on Day 2). Participants will be asked to maintain a clear fluid diet for a minimum of six hours prior to breath collection on both Day 1 and Day 2 of sampling.

Volunteers taking part in study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Volunteers will be recruited to provide breath samples in both Primary and Secondary Care environments.

You may qualify if:

  • Participants will be:
  • Aged ≥ 18 years old
  • Willing and able to provide informed consent to take part in study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Imperial College London

London, W12 0NN, United Kingdom

NOT YET RECRUITING

Imperial College London

London, United Kingdom

RECRUITING

MeSH Terms

Interventions

Breath Tests

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Michael Fadel, BSc MBBS MRCS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 24, 2024

Study Start

February 5, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 1, 2025

Record last verified: 2025-04

Locations